Author details

Full Name

Eric N Olson

Affiliation

ORCID

Career Start Year

1980

Papers

698

H Index

197

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37060194	CRISPR-Editing Therapy for Duchenne Muscular Dystrophy.		2023
36401041	CRISPR-Cas9 Correction of Duchenne Muscular Dystrophy in Mice by a Self-Complementary AAV Delivery System.	Methods in Molecular Biology	2023
37856214	CRISPR-Cas9 base editing of pathogenic CaMKIIÎ´ improves cardiac function in a humanized mouse model.		2023
37890031	RBPMS regulates cardiomyocyte contraction and cardiac function through RNA alternative splicing.		2023
37712250	Elimination of CaMKIIÎ´ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice.		2023
37972593	Transcription factor NFYa controls cardiomyocyte metabolism and proliferation during mouse fetal heart development.		2023
37955153	DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters.		2023
37770716	Cryo-EM structures of Myomaker reveal a molecular basis for myoblast fusion.		2023
36649395	Cardiac Reprogramming: Toward a Total Eclipse of the Failing Heart.		2023
36709593	Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies.		2023
37395273	Net39 protects muscle nuclei from mechanical stress during the pathogenesis of Emery-Dreifuss muscular dystrophy.		2023
34246567	Direct reprogramming as a route to cardiac repair.	Seminars in Cell and Developmental Biology	2022
36035749	A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing.	Molecular Therapy - Nucleic Acids	2022
35642635	Impaired activity of the fusogenic micropeptide Myomixer causes myopathy resembling Carey-Fineman-Ziter syndrome.	Journal of Clinical Investigation	2022
35472321	RBPMS is an RNA-binding protein that mediates cardiomyocyte binucleation and cardiovascular development.	Developmental Cell	2022
35402069	Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice.	Molecular Therapy - Nucleic Acids	2022
36417486	Precise genomic editing of pathogenic mutations in rescues dilated cardiomyopathy.	Science Translational Medicine	2022
36377660	Loss of function of the nuclear envelope protein LEMD2 causes DNA damage-dependent cardiomyopathy.	Journal of Clinical Investigation	2022
36254806	Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy.	Journal of Cachexia, Sarcopenia and Muscle	2022
34748394	Toward CRISPR Therapies for Cardiomyopathies.	Circulation	2021
34074727	Toward the correction of muscular dystrophy by gene editing.	Proceedings of the National Academy of Sciences of the United States of America	2021
33514739	The nuclear envelope protein Net39 is essential for muscle nuclear integrity and chromatin organization.	Nature Communications	2021
34038730	Cell-Type-Specific Gene Regulatory Networks Underlying Murine Neonatal Heart Regeneration at Single-Cell Resolution.	Cell Reports	2021
34571006	CRISPR/Cas correction of muscular dystrophies.	Experimental Cell Research	2021
34485599	A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation.	Molecular Therapy - Methods and Clinical Development	2021
34372664	Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy.	Circulation Research	2021
34875223	20 years of Developmental Cell: Looking back.	Dev Cell	2021
32892813	Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing.	Molecular Therapy	2020
31898733	Leaders in Cardiovascular Research: Eric Olson.	Cardiovascular Research	2020
32478678	Correction of muscular dystrophies by CRISPR gene editing.	Journal of Clinical Investigation	2020
32878549	Gene Therapy With the DWORF Micropeptide Attenuates Cardiomyopathy in Mice.	Circulation Research	2020
33290696	Dynamic Transcriptional Responses to Injury of Regenerative and Non-regenerative Cardiomyocytes Revealed by Single-Nucleus RNA Sequencing.	Developmental Cell	2020
31335328	Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.	JCI Insight	2019
31586095	In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse.	Nature Communications	2019
31604271	The intestinal microbiota programs diurnal rhythms in host metabolism through histone deacetylase 3.	Science	2019
30379597	CRISPR Correction of Duchenne Muscular Dystrophy.	Annual Review of Medicine	2019
30975722	Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.	Genes Dev	2019
31474563	Sema3a-Nrp1 Signaling Mediates Fast-Twitch Myofiber Specificity of Tw2 Cells.	Developmental Cell	2019
31080136	Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers.	Cell Stem Cell	2019
30742526	Secreted MG53 From Striated Muscle Impairs Systemic Insulin Sensitivity.	Circulation	2019
31451669	Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling.	Proceedings of the National Academy of Sciences of the United States of America	2019
31110021	NURR1 activation in skeletal muscle controls systemic energy homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2019
29581287	Fusogenic micropeptide Myomixer is essential for satellite cell fusion and muscle regeneration.	Proceedings of the National Academy of Sciences of the United States of America	2018
28432117	Control of Muscle Metabolism by the Mediator Complex.	Cold Spring Harbor Perspectives in Medicine	2018
30062188	Entrepreneurialism in the TranslationalÂ Biologic Sciences: Why, How, and However.	JACC: Basic to Translational Science	2018
29872165	Therapeutic approaches for cardiac regeneration and repair.	Nature Reviews Cardiology	2018
30531796	Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis.	Nature Communications	2018
30573475	Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease.	Development (Cambridge)	2018
29949755	MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid Î²-Oxidation.	Cell Rep	2018
30127033	Identification of a multipotent Twist2-expressing cell population in the adult heart.	Proc Natl Acad Sci U S A	2018